Characterizing the intestinal chondroitin sulfate glycosaminoglycan sulfation code in inflammatory bowel disease

被引：0
|
作者：
Francis, K. [1 ,2 ]
Zheng, H. [1 ]
Suskind, D. L. [1 ]
Phan, B. A. [2 ]
Nuding, M. [1 ]
Morton, G. [2 ]
Schwartz, M. [2 ]
Alonge, K. [2 ]
Scarlett, J. [1 ,2 ]
机构：
[1] Seattle Childrens Hosp, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2024年 / 72卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
346
引用
收藏
页码：392 / 393
页数：2
相关论文
共 50 条
  • [41] EFFECT OF CHONDROITIN SULPHATE ON PRO-INFLAMMATORY MEDIATORS AND DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Santos, F. A.
    Linares, P. M.
    Chaparro, M.
    Algaba, A.
    Martinez, M. R.
    Arza, I. M.
    Ochoa, D.
    San Jose, F. B.
    Gisbert, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 45 - 45
  • [42] Effect of Chondroitin Sulphate on Pro-Inflammatory Mediators and Disease Activity in Patients with Inflammatory Bowel Disease
    Linares, P. M.
    Chaparro, M.
    Algaba, A.
    Roman, M.
    Moreno Arza, I.
    Abad Santos, F.
    Ochoa, D.
    Guerra, I.
    Bermejo, F.
    Gisbert, J. P.
    DIGESTION, 2015, 92 (04) : 203 - 210
  • [43] Intestinal comorbidity: diverticular disease and chronic inflammatory bowel disease
    Krammer, H. -J.
    Schlieger, F.
    Wedel, T.
    DIVERTICULAR DISEASE: EMERGING EVIDENCE IN A COMMON CONDITION, 2006, 148 : 69 - +
  • [44] Characterizing the pre-clinical phase of inflammatory bowel disease
    Vestergaard, Marie Vibeke
    Allin, Kristine H.
    Poulsen, Gry J.
    Lee, James C.
    Jess, Tine
    CELL REPORTS MEDICINE, 2023, 4 (11)
  • [45] Effect of chondroitin sulphate on pro-inflammatory mediators and disease activity in patients with inflammatory bowel disease (IBD)
    Linares, P. M.
    Chaparro, M.
    Algaba, A.
    Guerra, I.
    Roman, M.
    Moreno Arza, I.
    Abad Santos, F.
    Ochoa, D.
    Bermejo, F.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S95 - S95
  • [46] Effect of Chondroitin Sulphate on Pro-Inflammatory Mediators and Disease Activity in Patients With Inflammatory Bowel Disease (IBD)
    Linares, Pablo M.
    Chaparro, Maria
    Algaba, Alicia
    Romÿn, Manuel
    Arza, M. Isabel Moreno
    Abad-Santos, Francisco
    Ochoa, Dolores
    Bermejo, Fernando
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2014, 146 (05) : S822 - S822
  • [47] Autophagy in intestinal fibrosis: relevance in inflammatory bowel disease
    Macias-Ceja, Dulce C.
    Barrachina, Maria D.
    Ortiz-Masia, Dolores
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [48] Intestinal microbiota in inflammatory bowel disease: Friend of foe?
    Fava, Francesca
    Danese, Silvio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (05) : 557 - 566
  • [49] The intestinal microvasculature as a therapeutic target in inflammatory bowel disease
    Hatoum, Ossama A.
    Heidemann, Jan
    Binion, David G.
    INFLAMMATORY BOWEL DISEASE: GENETICS, BARRIER FUNCTION, IMMUNOLOGIC MECHANISMS, AND MICROBIAL PATHWAYS, 2006, 1072 : 78 - 97
  • [50] Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
    Morgan, Xochitl C.
    Tickle, Timothy L.
    Sokol, Harry
    Gevers, Dirk
    Devaney, Kathryn L.
    Ward, Doyle V.
    Reyes, Joshua A.
    Shah, Samir A.
    LeLeiko, Neal
    Snapper, Scott B.
    Bousvaros, Athos
    Korzenik, Joshua
    Sands, Bruce E.
    Xavier, Ramnik J.
    Huttenhower, Curtis
    GENOME BIOLOGY, 2012, 13 (09):
12345